Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
165.86
+1.63 (+0.99%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractory follicular lymphoma after two or more lines of prior therapy.
Via
Benzinga
Exposures
Product Safety
2 Incredible Dividend Growth Stocks to Buy Right Now
June 27, 2024
These two dividend growth stocks can level up your portfolio.
Via
The Motley Fool
Is Johnson & Johnson Stock a Buy?
June 27, 2024
Johnson & Johnson's business is growing at a decent rate, but there's still a fair bit of risk surrounding the company.
Via
The Motley Fool
The 3 Smartest Dow Stocks to Buy With $1000 Right Now
June 26, 2024
Explore why these three well-known Dow stocks to buy are well worth your next $1,000 investment to grow your portfolio.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.
Via
Benzinga
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
June 24, 2024
Via
Benzinga
NYSE:JNJ, an undervalued stock with good fundamentals.
June 18, 2024
JOHNSON & JOHNSON (NYSE:JNJ) stands out as a stock that provides good value for the fundamentals it showcases.
Via
Chartmill
Market Analysis: Johnson & Johnson And Competitors In Pharmaceuticals Industry
June 17, 2024
Via
Benzinga
Is Johnson & Johnson the Best Dividend Stock for You?
June 25, 2024
J&J is the textbook blue chip stock -- but it's not for everyone.
Via
The Motley Fool
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
June 24, 2024
The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism in Iraq, dismissing a lower court's ruling and sending the case back for...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
June 22, 2024
The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields.
Via
The Motley Fool
2 Top Stocks to Buy Now for Years of Passive Income
June 22, 2024
These tried-and-true businesses could be wise additions to your portfolio.
Via
The Motley Fool
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson
June 17, 2024
Via
Benzinga
How Is The Market Feeling About Johnson & Johnson?
June 13, 2024
Via
Benzinga
Johnson & Johnson Faces New Lawsuit(s) Related To Its Talc Products
June 20, 2024
Johnson & Johnson faces a new class action lawsuit seeking damages and medical monitoring for cancer risk from talc products.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Johnson & Johnson's Arthritis Drug Shows Potential In Crohn's Disease
June 20, 2024
Johnson & Johnson announced that their Phase 3 GRAVITI study of Tremfya (guselkumab) SC therapy for Crohn's disease met all primary and secondary endpoints.
Via
Benzinga
3 Healthcare Stocks to Buy Now: June 2024
June 20, 2024
Invest in healthcare stocks to buy now, benefiting from robust product pipelines and tech advancements at this time.
Via
InvestorPlace
7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027
June 20, 2024
Discover these blue-chip stocks to buy in the biotechnology, banking, pharmaceuticals, tobacco, restaurants, and entertainment industries.
Via
InvestorPlace
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
June 20, 2024
These healthcare players offer you dividends and a strong earnings picture.
Via
The Motley Fool
3 No-Brainer Stocks to Buy With $500 Right Now
June 19, 2024
A modest amount of money can go a long when when it's put to work in game-changing businesses with well-defined catalysts.
Via
The Motley Fool
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
June 18, 2024
We ran a screener using Benzinga Pro to filter out three mega-cap stocks that are currently trading at attractive valuations.
Via
Benzinga
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
June 17, 2024
Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.
Via
Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
June 17, 2024
Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for...
Via
Benzinga
The 7 Best Under $20 Stocks to Buy in June 2024
June 15, 2024
Stocks may be ready to rally, here are seven of the best under $20 stocks to buy for those who still want value.
Via
InvestorPlace
Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices
June 15, 2024
Discover three beaten-down blue-chip stocks, including Johnson & Johnson, McDonald's and Accenture, with upside potential.
Via
InvestorPlace
Payout Powerhouses: 7 Dividend Stocks to Buy Now
June 13, 2024
Although growth ideas will probably always attract the market’s attention, it’s useful to balance your holdings with dividend stocks to buy.
Via
InvestorPlace
Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June
June 13, 2024
Here are three dividend stocks to buy for your retirement portfolio that should offer rising income beyond the rate of inflation.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
June 12, 2024
Via
Benzinga
Johnson & Johnson To Pay $700M To Settle Multi-State Talc Investigation
June 12, 2024
Although the settlement has been reached, Johnson & Johnson still faces a substantial number of talc-related lawsuits.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.